Rett Syndrome Drug Studied at Vanderbilt Approved for Patients
July 08, 2023
July 08, 2023
NASHVILLE, Tennessee, July 8 (TNSjou) -- Vanderbilt University Medical Center issued the following news:
The first drug to treat the symptoms of Rett syndrome was recently approved, following a Nature Medicine study publishing results from the pivotal phase 3 LAVENDER study led by investigators from Vanderbilt University Medical Center to evaluate efficacy and safety of trofinetide.
Positive findings from the study were integral to the Food and Drug Administration' . . .
The first drug to treat the symptoms of Rett syndrome was recently approved, following a Nature Medicine study publishing results from the pivotal phase 3 LAVENDER study led by investigators from Vanderbilt University Medical Center to evaluate efficacy and safety of trofinetide.
Positive findings from the study were integral to the Food and Drug Administration' . . .